To ask the Scottish Government, following the drug, exagamglogene autotemcel, being approved for use in England to treat sickle cell disease, what progress has been on approving it for use in Scotland. The Scottish Medicines Consortium (SMC) has not yet received a submission from the manufacturing company, Vertex, for exagamglogene autotemcel (Casgevy®...